Cargando…
[(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial
BACKGROUND: [(99m)Tc]Tilmanocept, a novel CD206 receptor-targeted radiopharmaceutical, was evaluated in an open-label, phase III trial to determine the false negative rate (FNR) of sentinel lymph node biopsy (SLNB) relative to the pathologic nodal status in patients with intraoral or cutaneous head...
Autores principales: | Agrawal, Amit, Civantos, Francisco J., Brumund, Kevin T., Chepeha, Douglas B., Hall, Nathan C., Carroll, William R., Smith, Russell B., Zitsch, Robert P., Lee, Walter T., Shnayder, Yelizaveta, Cognetti, David M., Pitman, Karen T., King, Dennis W., Christman, Lori A., Lai, Stephen Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565859/ https://www.ncbi.nlm.nih.gov/pubmed/25670018 http://dx.doi.org/10.1245/s10434-015-4382-x |
Ejemplares similares
-
Cost-Effectiveness of [(99m)Tc]Tilmanocept Relative to [(99m)Tc]Sulfur Colloid for Sentinel Lymph Node Biopsy in Early Stage Oral Cavity Cancer
por: Choi, Karen Y., et al.
Publicado: (2023) -
Additional non-sentinel lymph node metastases in early oral cancer patients with positive sentinel lymph nodes
por: Den Toom, Inne J., et al.
Publicado: (2016) -
Technetium Tc 99m tilmanocept fails to detect sentinel lymph nodes in endometrial cancer
por: Reddy, Ravali A., et al.
Publicado: (2022) -
Combined Analysis of Phase III Trials Evaluating [(99m)Tc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma
por: Sondak, Vernon K., et al.
Publicado: (2012) -
How many sentinel nodes should be harvested in oral squamous cell carcinoma?
por: Atula, Timo, et al.
Publicado: (2007)